Doxycycline Hyclate Tablet, Film Coated
NDC Package 24658-310-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Doxycycline Hyclate tablets is a medication used to treat a wide variety of bacterial infections, including those that cause acne. This formulation utilizes a tablet, film coated delivery system. Marketed by Puracap Laboratories Llc Dba Blu Pharmaceuticals, this product is identified by NDC 24658-310 and is authorized under FDA application ANDA062269.

Identification & Billing

NDC Package Code
24658-310-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
24658-310
11-Digit Billing Format
24658031030
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
RxCUI: 1650143 - doxycycline hyclate 100 MG Oral Tablet

Clinical Specifications

Proprietary Name
Doxycycline Hyclate
Non-Proprietary Name
Doxycycline Hyclate
Substance Name
Doxycycline Hyclate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DOXYCYCLINE HYCLATE 100 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Puracap Laboratories Llc Dba Blu Pharmaceuticals
Product Type
Human Prescription Drug
FDA Application #
ANDA062269
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-07-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24658-310). Click a package code to view its specific billing and regulatory data.

24658-310-01
100 TABLET, FILM COATED in 1 BOTTLE
24658-310-05
500 TABLET, FILM COATED in 1 BOTTLE
24658-310-07
300 TABLET, FILM COATED in 1 BOTTLE
24658-310-08
400 TABLET, FILM COATED in 1 BOTTLE
24658-310-10
1000 TABLET, FILM COATED in 1 BOTTLE
24658-310-20
20 TABLET, FILM COATED in 1 BOTTLE
24658-310-21
210 TABLET, FILM COATED in 1 BOTTLE
24658-310-50
50 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24658-310-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Doxycycline Hyclate, a human prescription drug labeled by Puracap Laboratories Llc Dba Blu Pharmaceuticals. This tablet, film coated is formulated for oral use and contains doxycycline hyclate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puracap Laboratories Llc Dba Blu Pharmaceuticals on March 07, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Puracap Laboratories Llc Dba Blu Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24658031030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24658-310-30
11-Digit CMS (5-4-2)
24658-0310-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.